Emerging Biopharma

Close-up of Benjamin Franklins eyes peering through hundred dollar bills
Biotech

Pfizer vet debuts Khartis with sights set on thyroid eye disease

Three years after Robert Hoffman sold XinThera to Gilead, the veteran Pfizer chemist has unveiled his latest venture.
Darren Incorvaia Aug 13, 2026 9:00am
cash money

Epicrispr bags $90M to rewrite treatment of rare muscle disease

Aug 11, 2026 10:30am
two arrows pointing different directions

Caldera hits Nasdaq via Synlogic reverse merger

Jul 29, 2026 8:56am
rocketship new blast off start up business development break off acquisition split

Lupin seeds US spinout with cash, clinical-stage cancer assets

Jul 21, 2026 8:20am
photo finish line

Biotechs forced to learn new patent tricks to protect pipelines

Jul 12, 2026 12:00pm
Worker bees in hive seen through honeycomb

Beeline bolsters autoimmune ambitions with $126M

Jun 30, 2026 7:00am
More News

Merck KGaA pledges $50M to new biotech with eye to acquisition

Jun 23, 2026 10:16am

With $30M, Oorja Bio breathes new life into fibrosis candidate

May 20, 2026 10:31am

Nominations now open for Fierce Biotech's 2026 Fierce 15

May 18, 2026 9:44am

Oryon shines out of stealth with $21M to fight Parkinson's

Mar 23, 2026 5:00am